ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising enhancements across various health-related and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, extra reliable different for therapeutic use, particularly